Lashuel, Hilal A. http://orcid.org/0000-0001-7682-8320
Mahul-Mellier, Anne-Laure http://orcid.org/0000-0002-7830-5483
Novello, Salvatore http://orcid.org/0000-0003-2157-1358
Hegde, Ramanath Narayana
Jasiqi, Yllza
Altay, Melek Firat
Donzelli, Sonia
DeGuire, Sean M.
Burai, Ritwik
Magalhães, Pedro http://orcid.org/0000-0001-8654-8752
Chiki, Anass
Ricci, Jonathan http://orcid.org/0000-0002-1326-166X
Boussouf, Manel
Sadek, Ahmed
Stoops, Erik
Iseli, Christian http://orcid.org/0000-0002-2296-2863
Guex, Nicolas http://orcid.org/0000-0001-6023-0519
Funding for this research was provided by:
Michael J. Fox Foundation for Parkinson's Research
Michael J. Fox Foundation for Parkinson's Research
Michael J. Fox Foundation for Parkinson's Research
Article History
Received: 29 March 2022
Accepted: 30 August 2022
First Online: 20 October 2022
Competing interests
: H.A.L. is the founder and chief scientific officer of ND BioSciences, Epalinges, Switzerland, a company that develops diagnostics and treatments for neurodegenerative diseases (NDs) based on platforms that reproduce the complexity and diversity of proteins implicated in NDs and their pathologies. H.A.L. is an editor for <i>npj Parkinson’s Disease</i>. H.A.L. was not involved in the journal’s review or decisions related to this manuscript and declares no non-financial competing interest. All other authors declare they do not have any competing interest.